Clomiphene for Low Testosterone: Fertility-Sparing in Australia

Wanting to start or grow a family while also dealing with the symptoms of low testosterone can feel like a real conflict. Standard testosterone replacement therapy (TRT) is very effective at restoring testosterone levels, but it carries an important drawback for men who want children: it can suppress sperm production. For some men — particularly younger men with secondary hypogonadism — an off-label medicine called clomiphene citrate offers a different path. Instead of replacing testosterone from outside the body, it prompts your own body to make more. Here is how it works, who it might suit, and why it should always be prescribed and monitored by a doctor.

How clomiphene citrate works

Your testosterone is governed by a feedback loop known as the hypothalamic–pituitary–gonadal (HPG) axis. In simple terms, the hypothalamus in your brain releases a signalling hormone that tells the pituitary gland to produce two others — luteinising hormone (LH) and follicle-stimulating hormone (FSH). LH prompts the testes to make testosterone, while FSH supports sperm production. Oestrogen, which men also produce in small amounts (partly converted from testosterone), feeds back to the brain to keep this loop in balance.

Clomiphene citrate is a selective oestrogen receptor modulator, or SERM. It gently blocks oestrogen's feedback signal at the level of the hypothalamus and pituitary. The brain reads this as low oestrogen and responds by increasing LH and FSH, which in turn stimulate the testes to produce more of your own testosterone while continuing to support sperm production. In other words, clomiphene works with your natural hormonal machinery rather than bypassing it.

Why TRT can reduce fertility — and clomiphene usually does not

Conventional TRT works by supplying testosterone from an external source, such as an injection or a gel. Because your brain senses that testosterone is already plentiful, it winds down its own signals and LH and FSH fall. As those signals drop, the testes reduce their internal testosterone production and, importantly, their sperm output. This is why the Endocrine Society's clinical practice guideline advises against starting testosterone therapy in men who wish to father children in the near future. TRT can also cause the testes to shrink, and while fertility often recovers after stopping, this is not guaranteed and can take many months.

Clomiphene takes the opposite approach. Because it keeps the HPG axis switched on — raising rather than suppressing LH and FSH — it can lift testosterone while preserving the testicular signals needed to keep making sperm. That fertility-sparing quality is the main reason it is considered for men who are trying to conceive. You can read more in our guide to TRT and fertility in Australia.

Who might clomiphene suit?

Clomiphene is not a universal alternative to TRT. It relies on the testes being able to respond to LH and FSH, so it is generally only an option for men with secondary hypogonadism — where low testosterone stems from reduced signalling from the brain rather than a problem with the testes themselves. In primary hypogonadism, where the testes cannot respond adequately, clomiphene is unlikely to help.

It tends to be considered for:

• younger men with low testosterone who want to preserve or restore their fertility
• men with confirmed secondary hypogonadism whose testes are still able to respond
• men who would prefer to avoid lifelong external testosterone if a fertility-sparing option is suitable

Working out whether you have primary or secondary hypogonadism — and whether a reversible cause is present — requires proper assessment. In Australia, the Endocrine Society of Australia position statement recommends confirming low testosterone with repeat morning blood tests and measuring LH and FSH to help pinpoint the cause before deciding on treatment. If you are under 40, our articles on low testosterone in men under 40 and secondary hypogonadism explain this in more detail.

What the evidence shows

The study most often cited in this area is by Katz and colleagues, published in BJU International in 2012. In a group of young men with hypogonadism treated with clomiphene citrate, the medicine significantly increased their own testosterone levels — on average into the normal range — and was associated with an improvement in symptoms of testosterone deficiency. It was generally well tolerated, with few adverse effects reported.

These findings are encouraging, and they support clomiphene as a reasonable fertility-sparing option for carefully selected men. It is worth staying realistic, though: the evidence base for clomiphene in men is smaller and less robust than the large randomised trials behind conventional TRT, and much of it comes from observational studies rather than long-term controlled trials. Response varies from person to person, and clomiphene does not suit everyone.

Off-label status and medical supervision in Australia

In Australia, clomiphene citrate is approved by the Therapeutic Goods Administration (TGA) for treating infertility in women — not for low testosterone in men. Using it to raise testosterone is therefore an 'off-label' use. Off-label prescribing is legitimate and common in medicine, but it means the medicine has not been formally evaluated and approved by the regulator for this specific purpose, so it should always involve a clear discussion of the potential benefits, risks and uncertainties, along with your informed consent.

For that reason, clomiphene should only be used under the supervision of a GP working with — or with input from — a relevant specialist such as an endocrinologist, urologist or fertility specialist. Sensible supervision usually includes:

• confirming the diagnosis and the cause of low testosterone before starting
• baseline and follow-up blood tests, including testosterone, LH, FSH and oestradiol
• reviewing symptoms and any side effects, which can include mood changes and, less commonly, visual disturbances — blurred vision or flashing lights should prompt you to stop and contact your doctor
• deciding together whether the treatment is working and worth continuing

Because this is an off-label use, clomiphene may not be subsidised through the PBS for this purpose, so it is worth discussing costs with your doctor. Like testosterone itself, clomiphene is a prescription-only medicine and should never be sourced online or from overseas without proper medical oversight.

The bottom line

Clomiphene citrate is an off-label, fertility-sparing option that can raise low testosterone by stimulating your body's own production — while, unlike TRT, preserving sperm production. It is most relevant for younger men with secondary hypogonadism who want to protect their fertility. The evidence, led by the Katz study, suggests it can meaningfully lift testosterone and improve symptoms in well-chosen patients, though the research base is more limited than for standard TRT. It is not a do-it-yourself treatment: it needs proper testing to confirm the diagnosis and cause, an honest conversation about its off-label status, and ongoing monitoring by an AHPRA-registered GP and, where appropriate, a specialist. If preserving your fertility matters, raise it early — ideally before starting any testosterone treatment — so the right option can be chosen from the outset.

References

1. Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
2. Yeap BB, et al. Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy. Med J Aust. 2016;205(4):173-178. https://www.mja.com.au/journal/2016/205/4/endocrine-society-australia-position-statement-male-hypogonadism-part-1
3. Katz DJ, et al. Outcomes of clomiphene citrate treatment in young hypogonadal men. BJU Int. 2012;110(4):573-578. https://pubmed.ncbi.nlm.nih.gov/22044663/

This article is general information only and is not a substitute for personalised medical advice. Testosterone is a prescription-only (S4) medicine in Australia and is prescribed only where clinically appropriate. Speak with an AHPRA-registered GP about your individual situation.